Dr. Molly Shoichet PhD

Co-Founder & Chief Science Officer

Chemical & Biomedical Engineer
Polymer design and drug delivery expert

Molly co-founded AmacaThera in 2016 and is a University Professor at the University of Toronto, where her research focuses on drug and cell delivery strategies in the central nervous system (brain, spinal cord and retina) and 3D hydrogel culture systems to model cancer. Molly has published over 650 papers, patents and abstracts and has given over 420 lectures worldwide. She currently leads a laboratory of 30 and has graduated 220 researchers.

Molly has received many prestigious distinctions and is the only person to be inducted into all three of Canada’s National Academies of Science of the Royal Society of Canada, Engineering and Health Sciences. In 2018, she was inducted as an Officer of the Order of Canada and in 2011, she was awarded the Order of Ontario. Molly was the L’Oreal-UNESCO For Women in Science Laureate for North America in 2015, elected Foreign Member of the US National Academy of Engineering in 2016, won the Killam Prize in Engineering in 2017, elected to the Royal Society (UK) in 2019 and awarded the NSERC Herzberg Gold Medal in 2020. She served as Ontario’s first Chief Scientist in 2018 where she worked to enhance the culture of science.

Molly received her Bachelor of Science from the Massachusetts Institute of Technology (1987) and her PhD from the University of Massachusetts, Amherst in Polymer Science and Engineering (1992).

Dr Molly Shoichet v2
Amacathera Logo

AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.

Contact Us

MaRS Centre, West Tower,
661 University Ave Suite 1300,
Toronto, ON M5G 0B7

[email protected]